» Articles » PMID: 31674301

Direct Estimation of Sensitivity of Rapid Diagnostic Test for Active Case Detection in a High-Transmission Community Setting

Overview
Specialty Tropical Medicine
Date 2019 Nov 2
PMID 31674301
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Community-based active case detection of malaria parasites with conventional rapid diagnostic tests (cRDTs) is a strategy used most commonly in low-transmission settings. We estimated the sensitivity of this approach in a high-transmission setting in Western Kenya. We tested 3,547 members of 912 households identified in 2013-2014 by index children with (case) and without (control) cRDT-positive malaria. All were tested for with both a cRDT targeting histidine-rich protein 2 and with an ultrasensitive real-time polymerase chain reaction (PCR). We computed cRDT sensitivity against PCR as the referent, compared prevalence between participant types, and estimated cRDT detectability as a function of PCR-estimated parasite density. Parasite prevalence was 22.9% by cRDTs and 61.5% by PCR. Compared with children aged < 5 years or adults aged > 15 years, geometric mean parasite densities (95% CI) were highest in school-age children aged 5-15 years (8.4 p/uL; 6.6-10.6). The overall sensitivity of cRDT was 36%; among asymptomatic household members, cRDT sensitivity was 25.5% and lowest in adults aged > 15 years (15.8%). When modeled as a function of parasite density, relative to school-age children, the probability of cRDT positivity was reduced in both children aged < 5 years (odds ratio [OR] 0.48; 95% CI: 0.34-0.69) and in adults aged > 15 years (OR: 0.35; 95% CI: 0.27-0.47). An HRP2-detecting cRDT had poor sensitivity for active case detection in asymptomatic community members, and sensitivity was lowest in highly prevalent low-density infections and in adults. Future studies can model the incremental effects of high-sensitivity rapid diagnostic tests and the impacts on transmission.

Citing Articles

Effects on maternal and pregnancy outcomes of first-trimester malaria infection among nulliparous women from Kenya, Zambia, and the Democratic Republic of the Congo.

Leuba S, Westreich D, Bose C, Olshan A, Taylor S, Tshefu A PLoS One. 2024; 19(12):e0310339.

PMID: 39705264 PMC: 11661578. DOI: 10.1371/journal.pone.0310339.


Analytic optimization of Plasmodium falciparum marker gene haplotype recovery from amplicon deep sequencing of complex mixtures.

Lapp Z, Freedman E, Huang K, Markwalter C, Obala A, Prudhomme-OMeara W PLOS Glob Public Health. 2024; 4(5):e0002361.

PMID: 38814915 PMC: 11139333. DOI: 10.1371/journal.pgph.0002361.


Risk of Malaria Following Untreated Subpatent Plasmodium falciparum Infections: Results Over 4 Years From a Cohort in a High-Transmission Area in Western Kenya.

Zeno E, Obala A, Pence B, Freedman E, Mangeni J, Lin J J Infect Dis. 2023; 229(4):969-978.

PMID: 37713614 PMC: 11011184. DOI: 10.1093/infdis/jiad398.


Symptomatic malaria enhances protection from reinfection with homologous Plasmodium falciparum parasites.

Markwalter C, Petersen J, Zeno E, Sumner K, Freedman E, Mangeni J PLoS Pathog. 2023; 19(6):e1011442.

PMID: 37307293 PMC: 10289385. DOI: 10.1371/journal.ppat.1011442.


Field evaluation of the novel One Step Malaria Pf and Pf/Pv rapid diagnostic tests and the proportion of HRP-2 gene deletion identified on samples collected in the Pwani region, Tanzania.

Mwangonela Z, Ye Y, Rachel Q, Msuya H, Mwamlima T, Mswata S Bull Natl Res Cent. 2023; 47(1):17.

PMID: 36776799 PMC: 9904258. DOI: 10.1186/s42269-023-00992-4.


References
1.
Das S, Peck R, Barney R, Jang I, Kahn M, Zhu M . Performance of an ultra-sensitive Plasmodium falciparum HRP2-based rapid diagnostic test with recombinant HRP2, culture parasites, and archived whole blood samples. Malar J. 2018; 17(1):118. PMC: 5857316. DOI: 10.1186/s12936-018-2268-7. View

2.
Hofmann N, Gruenberg M, Nate E, Ura A, Rodriguez-Rodriguez D, Salib M . Assessment of ultra-sensitive malaria diagnosis versus standard molecular diagnostics for malaria elimination: an in-depth molecular community cross-sectional study. Lancet Infect Dis. 2018; 18(10):1108-1116. DOI: 10.1016/S1473-3099(18)30411-0. View

3.
Gueye C, Sanders K, Galappaththy G, Rundi C, Tobgay T, Sovannaroth S . Active case detection for malaria elimination: a survey among Asia Pacific countries. Malar J. 2013; 12:358. PMC: 3852840. DOI: 10.1186/1475-2875-12-358. View

4.
Deutsch-Feldman M, Hamapumbu H, Lubinda J, Musonda M, Katowa B, Searle K . Efficiency of a Malaria Reactive Test-and-Treat Program in Southern Zambia: A Prospective, Observational Study. Am J Trop Med Hyg. 2018; 98(5):1382-1388. PMC: 5953385. DOI: 10.4269/ajtmh.17-0865. View

5.
Chihanga S, Haque U, Chanda E, Mosweunyane T, Moakofhi K, Jibril H . Malaria elimination in Botswana, 2012-2014: achievements and challenges. Parasit Vectors. 2016; 9:99. PMC: 4765051. DOI: 10.1186/s13071-016-1382-z. View